Zephyr Valve Japan Post-Marketing Surveillance
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorPulmonx Corporation
About this trial
This is a multicenter, prospective, observational surveillance enrolling 140 consecutive patients with severe emphysema who are candidates for bronchoscopic lung volume reduction using Zephyr Endobronchial Valve at up to 20 centers across Japan and followed for 12 months.
Eligibility criteria
Qualifiers
Recent respiratory rehabilitation completed within the last 6 months
Not actively smoking (for at least 4 months)
TLC ≥ 100%
RV ≥ 175%
Disqualifiers
None
Trial design
Treatments tested in this trial
- Zephyr Endobronchial Valve
Treatment groups
140 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov